Decoding RNA therapeutics: Precision approaches in women's health

Area of Science:

• Biotechnology
• Genomics
• Women's Health

Background:

• RNA-based technologies represent a significant advancement in precision medicine.
• Women's health faces complex and underdiagnosed conditions requiring innovative therapeutic strategies.

Purpose of the Study:

• To provide a comprehensive review of current RNA-targeted therapies and their applications in women's health.
• To highlight advances in drug delivery, diagnostics, and pharmacogenomics for RNA therapeutics.
• To address biological, hormonal, ethical, regulatory, and equity considerations specific to female populations.

Main Methods:

• Literature review of current RNA-targeted therapies including mRNA vaccines, RNA interference (RNAi), antisense oligonucleotides, and non-coding RNA modulators.
• Analysis of applications in gynecological cancers, reproductive disorders, pregnancy complications, and hormone-related conditions.
• Examination of drug delivery systems (e.g., lipid nanoparticles), companion diagnostics, and pharmacogenomics.

Main Results:

• RNA therapeutics show promise across diverse women's health areas, including oncology and reproductive health.
• Advances in delivery systems and precision medicine are enhancing therapeutic efficacy.
• Biological and hormonal differences necessitate tailored approaches, alongside ethical and equity considerations.

Conclusions:

• RNA therapeutics hold transformative potential for personalized interventions in women's health.
• Multidisciplinary research and emerging technologies like CRISPR and AI are expanding the therapeutic frontier.
• Optimizing RNA therapeutics requires a focus on biological specificity, ethical deployment, and equitable access for women globally.